These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4139672)

  • 1. [Administration of encephalitogenic basic protein in the diagnosis of multiple sclerosis and Guillain-Barré syndrome].
    Wajgt A; Wiktorowicz K; Torliński L
    Neurol Neurochir Pol; 1974; 8(5):653-62. PubMed ID: 4139672
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum IgE concentrations in neurological diseases.
    Huang JT
    Ann Allergy; 1975 Jan; 34(1):1-6. PubMed ID: 808150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serologic tests with the use of encephalitogenic protein in the diagnosis of multiple scerosis].
    Wajgt A; Torliński L; Chmielewska U
    Neurol Neurochir Pol; 1975; 9(2):185-91. PubMed ID: 50571
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-mediated immunity to myelin basic protein in acute disseminated encephalomyelitis.
    Lisak RP; Behan PO; Zweiman B; Shetty T
    Neurology; 1974 Jun; 24(6):560-4. PubMed ID: 4133960
    [No Abstract]   [Full Text] [Related]  

  • 5. The ophthalmoplegic form of the Guillain-Barre-syndrome: an immunologic study.
    Behan PO; Geschwind N
    Acta Ophthalmol (Copenh); 1973; 51(4):529-42. PubMed ID: 4128797
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple sclerosis, Guillain-Barré syndrome and myelin basic protein-specific cellular antibody.
    Johnson AB; Dal Canto MC
    Nature; 1976 Dec; 264(5585):453-4. PubMed ID: 1004578
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of I-125 labeled encephalitogenic protein on the surface of blood lymphocytes].
    Diessner H; Neumann V; Schmidt RM
    Schweiz Arch Neurol Neurochir Psychiatr; 1974; 114(1):57-66. PubMed ID: 4133176
    [No Abstract]   [Full Text] [Related]  

  • 8. Retrobulbar neuritis as an early symptom of Guillain-Barre syndrome. Report of a case.
    Nikoskelainen E; Riekkinen P
    Acta Ophthalmol (Copenh); 1972; 50(1):111-5. PubMed ID: 4338297
    [No Abstract]   [Full Text] [Related]  

  • 9. Radioimmunoassay of CSF for encephalitogenic basic protein: a diagnostic test for MS?
    McPherson TA; Gilpin A; Seland TP
    Can Med Assoc J; 1972 Nov; 107(9):856-9. PubMed ID: 4120149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular hypersensitivity to basic myelin (P2) protein in the Guillain-Barré syndrome.
    Sheremata W; Colby S; Karkhanis Y; Eylar EH
    Can J Neurol Sci; 1975 May; 2(2):87-90. PubMed ID: 165869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of antimyelin antibodies by immunofluorescence in Guillain-Barré syndrome.
    Tse KS; Arbesman CE; Tomasi TB; Tourville D
    Clin Exp Immunol; 1971 Jun; 8(6):881-7. PubMed ID: 4997072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating immune complexes in multiple sclerosis and other neurological diseases.
    Tachovsky TG; Lisak RP; Koprowski H; Theofilopoulos AN; Dixon FJ
    Lancet; 1976 Nov; 2(7993):997-9. PubMed ID: 62267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological aspects of the Guillain-Barré syndrome.
    Lancet; 1971 Jun; 1(7713):1340-1. PubMed ID: 4103758
    [No Abstract]   [Full Text] [Related]  

  • 14. Encephalitogenic peptide and platelet aggregation in multiple sclerosis.
    Prosiegel M; Neu I; Mehlber L
    Acta Neurol Scand; 1986 Feb; 73(2):141-4. PubMed ID: 2422865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous-tissue antigens.
    Rocklin RE; Sheremata WA; Feldman RG; Kies MW; David JR
    N Engl J Med; 1971 Apr; 284(15):803-8. PubMed ID: 4323673
    [No Abstract]   [Full Text] [Related]  

  • 16. The ultrastructure of circulating immunocytes in Guillain-Barré syndrome.
    Whitaker JN; Hirano COOK SD; Dowling PC
    Neurology; 1970 Aug; 20(8):765-70. PubMed ID: 5465846
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimyelin antibodies in neurologic diseases. Immunofluorescent demonstration.
    Lisak RP; Zwiman B; Norman M
    Arch Neurol; 1975 Mar; 32(3):163-7. PubMed ID: 804300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum immunoglobulins in the Guillain-Barré syndrome.
    Cook SD; Dowling PC; Whitaker JN
    Neurology; 1970 Apr; 20(4):403. PubMed ID: 4104905
    [No Abstract]   [Full Text] [Related]  

  • 19. Myelin encephalitogenic protein fragments in cerebrospinal fluid of persons with multiple sclerosis.
    Whitaker JN
    Neurology; 1977 Oct; 27(10):911-20. PubMed ID: 71667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Guillain-Barré syndrome. Relationship of circulating immunocytes to disease activity.
    Cook SD; Dowling PC; Whitaker JN
    Arch Neurol; 1970 May; 22(5):470-4. PubMed ID: 5435670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.